Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$246M |
| 2 |
ExxonMobil
XOM
|
+$96.1M |
| 3 |
Apple
AAPL
|
+$62M |
| 4 |
Verizon
VZ
|
+$58.6M |
| 5 |
Boeing
BA
|
+$52.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$174M |
| 2 |
SE
Spectra Energy Corp Wi
SE
|
+$85.4M |
| 3 |
STJ
St Jude Medical
STJ
|
+$69M |
| 4 |
Caterpillar
CAT
|
+$63.8M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.76% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 12.7% |
| 4 | Industrials | 11.05% |
| 5 | Consumer Discretionary | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YELL
2201
DELISTED
Yellow Corporation Common Stock
YELL
| $1.98M | ﹤0.01% |
179,737
-59,907
| -25% | -$777K |
|
2202
Globalstar
GSAT
$10.9B
| $1.97M | ﹤0.01% |
81,982
+21,160
| +35% | +$475K |
|
2203
Cerus
CERS
$508M
| $1.96M | ﹤0.01% |
439,172
+25,530
| +6% | +$108K |
|
|
MGI
2204
DELISTED
MoneyGram International, Inc. New
MGI
| $1.95M | ﹤0.01% |
116,195
+6,498
| +6% | +$87.4K |
|
|
LDR
2205
DELISTED
Landauer Inc
LDR
| $1.95M | ﹤0.01% |
40,046
+5,123
| +15% | +$260K |
|
|
ESPR
2206
DELISTED
Esperion Therapeutics
ESPR
| $1.95M | ﹤0.01% |
55,129
+9,478
| +21% | +$217K |
|
2207
Caesars Entertainment
CZR
$6.13B
| $1.94M | ﹤0.01% |
102,698
+4,959
| +5% | +$83.6K |
|
2208
Accuray
ARAY
$34.9M
| $1.94M | ﹤0.01% |
408,220
-243,074
| -37% | -$1.27M |
|
|
AY
2209
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $1.94M | ﹤0.01% |
92,484
| – | – |
|
2210
Chegg
CHGG
$94.8M
| $1.94M | ﹤0.01% |
229,459
+10,602
| +5% | +$81.8K |
|
|
UAM
2211
DELISTED
Universal American Corp
UAM
| $1.93M | ﹤0.01% |
193,631
+10,773
| +6% | +$107K |
|
2212
Alibaba
BABA
$317B
| $1.93M | ﹤0.01% |
17,898
+3,027
| +20% | +$308K |
|
2213
ANI Pharmaceuticals
ANIP
$1.74B
| $1.93M | ﹤0.01% |
38,906
+10,489
| +37% | +$589K |
|
|
RVNC
2214
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.92M | ﹤0.01% |
92,490
+3,933
| +4% | +$80.8K |
|
|
RRTS
2215
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $1.92M | ﹤0.01% |
11,163
+2,765
| +33% | +$571K |
|
|
ACHN
2216
DELISTED
Achillion Pharmaceuticals
ACHN
| $1.91M | ﹤0.01% |
454,491
+25,650
| +6% | +$107K |
|
2217
Artivion
AORT
$1.28B
| $1.91M | ﹤0.01% |
114,544
+5,985
| +6% | +$106K |
|
2218
Westwood Holdings Group
WHG
$183M
| $1.91M | ﹤0.01% |
35,660
+1,869
| +6% | +$107K |
|
2219
Enel Chile
ENIC
$6.2B
| $1.9M | ﹤0.01% |
345,487
+50,374
| +17% | +$251K |
|
2220
Medifast
MED
$135M
| $1.9M | ﹤0.01% |
42,743
+2,223
| +5% | +$95.7K |
|
|
AIMT
2221
DELISTED
Aimmune Therapeutics
AIMT
| $1.89M | ﹤0.01% |
87,057
+4,788
| +6% | +$98.2K |
|
|
INOV
2222
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $1.89M | ﹤0.01% |
149,727
-2,321
| -2% | -$26.9K |
|
2223
Virtu Financial
VIRT
$4.92B
| $1.88M | ﹤0.01% |
110,583
+7,353
| +7% | +$127K |
|
|
RATE
2224
DELISTED
Bankrate Inc
RATE
| $1.88M | ﹤0.01% |
194,678
+10,773
| +6% | +$117K |
|
|
XOXO
2225
DELISTED
Xo Group Inc
XOXO
| $1.87M | ﹤0.01% |
108,672
+5,943
| +6% | +$108K |
|
Similar funds
Charles Schwab's Q1 2017 Portfolio in Review
As of Q1 2017, Charles Schwab held 3,112 positions worth $99.9B, up 9.4% from $91.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $4.38B of net new capital in Q1 2017, opening 37 new positions and adding to 2,360 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 413,073 shares worth $22.5M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Chevron, an estimated $174M trimmed.
- Charles Schwab's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 413,073 shares worth $22.5M.
- Charles Schwab added most to Home Depot in Q1 2017, an estimated $246M increase.
- Charles Schwab's biggest Q1 2017 reduction was Chevron, cutting an estimated $174M.
- Charles Schwab fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $85.4M.
- Charles Schwab's ten largest holdings make up 14% of its $99.9B portfolio in Q1 2017.
- Charles Schwab opened 37 new positions and closed 57 in Q1 2017.
- Charles Schwab's portfolio value rose 9.4% quarter-over-quarter to $99.9B.
Based on Charles Schwab's 13F filing for Q1 2017, filed 15 May 2017.